175 related articles for article (PubMed ID: 34113343)
1. Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis.
Pearson MS; Tedla BA; Becker L; Nakajima R; Jasinskas A; Mduluza T; Mutapi F; Oeuvray C; Greco B; Sotillo J; Felgner PL; Loukas A
Front Immunol; 2021; 12():663041. PubMed ID: 34113343
[TBL] [Abstract][Full Text] [Related]
2. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
[TBL] [Abstract][Full Text] [Related]
3. Helminth parasite proteomics: from experimental models to human infections.
Mutapi F
Parasitology; 2012 Aug; 139(9):1195-204. PubMed ID: 22455721
[TBL] [Abstract][Full Text] [Related]
4. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
[TBL] [Abstract][Full Text] [Related]
5.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma japonicum calcium-binding tegumental protein SjTP22.4 immunization confers praziquantel schistosomulumicide and antifecundity effect in mice.
Zhang Z; Xu H; Gan W; Zeng S; Hu X
Vaccine; 2012 Jul; 30(34):5141-50. PubMed ID: 22683520
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody against Schistosoma haematobium soluble egg antigen: efficacy for diagnosis and monitoring of cure of S. haematobium infection.
Salah F; Demerdash Z; Shaker Z; El Bassiouny A; El Attar G; Ismail S; Badir N; El Din AS; Mansour M
Parasitol Res; 2000 Jan; 86(1):74-80. PubMed ID: 10669141
[TBL] [Abstract][Full Text] [Related]
8. Immune attrition of adult schistosomes.
Agnew AM; Murare HM; Doenhoff MJ
Parasite Immunol; 1993 May; 15(5):261-71. PubMed ID: 8332382
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S. mansoni.
Boulanger D; Warter A; Trottein F; Mauny F; Brémond P; Audibert F; Couret D; Kadri S; Godin C; Sellin E
Parasite Immunol; 1995 Jul; 17(7):361-9. PubMed ID: 8552409
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.
Riveau G; Schacht AM; Dompnier JP; Deplanque D; Seck M; Waucquier N; Senghor S; Delcroix-Genete D; Hermann E; Idris-Khodja N; Levy-Marchal C; Capron M; Capron A
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006968. PubMed ID: 30532268
[TBL] [Abstract][Full Text] [Related]
11. Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes.
de Souza C; Lopes MD; De Oliveira FM; Passos MJF; Ferreira LCG; Faria BF; Villar JAFP; Junior MC; Taranto AG; Dos Santos LL; Fonseca CT; de Oliveira Lopes D
Mol Immunol; 2018 Jan; 93():133-143. PubMed ID: 29175593
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of serological responses to defined recombinant proteins during Schistosoma mansoni infection in mice before and after the treatment with praziquantel.
Mohammed ES; Nakamura R; Kalenda YD; Deloer S; Moriyasu T; Tanaka M; Fujii Y; Kaneko S; Hirayama K; Ibrahim AI; El-Seify MA; Metwally AM; Hamano S
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008518. PubMed ID: 32915790
[TBL] [Abstract][Full Text] [Related]
13. Immune events associated with protection in C57BL/6 mice immunized with anti-idiotypic antibodies mimicking protective antigens shared between gamma-irradiated cercariae vaccine and human resistance model of Schistosoma haematobium.
Abdeen SH
Egypt J Immunol; 2010; 17(2):105-19. PubMed ID: 23082491
[TBL] [Abstract][Full Text] [Related]
14. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
Fallon PG; Doenhoff MJ
Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
[TBL] [Abstract][Full Text] [Related]
15. Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter.
Siddiqui AJ; Molehin AJ; Zhang W; Ganapathy PK; Kim E; Rojo JU; Redman WK; Sennoune SR; Sudduth J; Freeborn J; Hunter D; Kottapalli KR; Kottapalli P; Wettashinghe R; van Dam GJ; Corstjens PLAM; Papin JF; Carey D; Torben W; Ahmad G; Siddiqui AA
Ann N Y Acad Sci; 2018 Aug; 1425(1):19-37. PubMed ID: 29888790
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
Leow CY; Willis C; Leow CH; Hofmann A; Jones M
Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
[TBL] [Abstract][Full Text] [Related]
17. Schistosome vaccines: current progress and future prospects.
Sher A; James SL; Correa-Oliveira R; Hieny S; Pearce E
Parasitology; 1989; 98 Suppl():S61-8. PubMed ID: 2498828
[TBL] [Abstract][Full Text] [Related]
18. Immunological analysis of cloned Schistosoma mansoni antigens Sm31 and Sm32 with sera of schistosomiasis patients.
Klinkert MQ; Bommert K; Moser D; Felleisen R; Link G; Doumbo O; Beck E
Trop Med Parasitol; 1991 Dec; 42(4):319-24. PubMed ID: 1796225
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma bovis as an immunological analogue of S. haematobium.
Agnew AM; Murare HM; Lucas SB; Doenhoff MJ
Parasite Immunol; 1989 Jul; 11(4):329-40. PubMed ID: 2506507
[TBL] [Abstract][Full Text] [Related]
20. Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.
Mutapi F; Mduluza T; Gomez-Escobar N; Gregory WF; Fernandez C; Midzi N; Maizels RM
BMC Infect Dis; 2006 Jun; 6():96. PubMed ID: 16764709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
